1. |
- Broesby-Olsen, Sigurd, et al.
(author)
-
Multidisciplinary Management of Mastocytosis : Nordic Expert Group Consensus
- 2016
-
In: Acta Dermato-Venereologica. - : Medical Journals Sweden AB. - 0001-5555 .- 1651-2057. ; 96:5
-
Journal article (peer-reviewed)abstract
- Mastocytosis is a heterogeneous group of diseases defined by an increased number and accumulation of mast cells, and often also by signs and symptoms of mast cell activation. Disease subtypes range from indolent to rare aggressive forms. Mastocytosis affects people of all ages and has been considered rare; however, it is probably underdiagnosed with potential severe implications. Diagnosis can be challenging and symptoms may be complex and involve multiple organ-systems. In general it is advised that patients should be referred to centres with experience in the disease offering an individualized, multidisciplinary approach. We present here consensus recommendations from a Nordic expert group for the diagnosis and general management of patients with mastocytosis.
|
|
2. |
-
Handbook of Pre-Modern Nordic Memory Studies : Interdisciplinary Approaches
- 2018
-
Editorial collection (peer-reviewed)abstract
- In recent years, the field of Memory Studies has emerged as a key approach in the Humanities and Social Sciences, and has increasingly shown its ability to open new windows on Nordic Studies as well. The entries in this book document the work-to-date of this approach on the pre-modern Nordic world (mainly the Viking Age and the Middle Ages, but including as well both earlier and later periods). Given that Memory Studies is an ever expanding critical strategy, the approximately eighty contributors in this volume also discuss the potential for future research in this area. Topics covered range from texts to performance to visual and other aspects of material culture, all approached from within an interdisciplinary framework. International specialists, coming from such relevant fields as archaeology, mythology, history of religion, folklore, history, law, art, literature, philology, language, and mediality, offer assessments on the relevance of Memory Studies to their disciplines and show it at work in case studies. Finally, this handbook demonstrates the various levels of culture where memory had a critical impact in the pre-modern North and how deeply embedded the role of memory is in the material itself.• interdisciplinary volume on memory studies in Viking Age and medieval Scandinavia• texts and images illustrating the role of memory studies for the Old Norse world• entries and case studies by nearly 80 specialists representing a wide variety of fields
|
|
3. |
|
|
4. |
|
|
5. |
|
|
6. |
- Lauterlein, Jens Jacob L., et al.
(author)
-
Serum sclerostin and glucose homeostasis : No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study
- 2021
-
In: Bone. - : Elsevier BV. - 8756-3282. ; 143
-
Journal article (peer-reviewed)abstract
- Introduction: Sclerostin, an inhibitor of bone formation, has emerged as a potential negative regulator of glucose homeostasis. We aimed to investigate if serum sclerostin associates with insulin sensitivity, beta cell function, prediabetes or metabolic syndrome in healthy men. Materials and methods: Serum sclerostin was measured in basal and insulin-stimulated samples from 526 men without diabetes from the RISC cohort study. An OGTT was performed at baseline and after 3 years. An IVGTT and a hyperinsulinaemic-euglycaemic clamp were performed at baseline. Insulin sensitivity was estimated by the oral glucose sensitivity index (OGIS) and the M-value relative to insulin levels. Beta cell function was assessed by the acute and total insulin secretion (ISRtot) and by beta cell glucose sensitivity. Results: Serum sclerostin levels correlated positively with age but were similar in individuals with (n = 69) and without (n = 457) prediabetes or the metabolic syndrome. Serum sclerostin was associated with measures of neither insulin sensitivity nor beta cell function at baseline in age-adjusted analyses including all participants. However, baseline serum sclerostin correlated inversely with OGIS at follow-up in men without prediabetes (B: −0.29 (−0.57, −0.01) p = 0.045), and inversely with beta cell glucose sensitivity in men with prediabetes (B: −13.3 (−26.3, −0.2) p = 0.046). Associations between serum sclerostin and 3-year changes in measures of glucose homeostasis were not observed. Acute hyperinsulinemia suppressed serum sclerostin (p = 0.02), and this reduction correlated with OGIS and ISRtot. Conclusions: Overall, serum sclerostin was not associated with prediabetes, insulin sensitivity or insulin secretion in healthy men. The inverse relationship between serum sclerostin and insulin sensitivity at follow-up was weak and likely not of clinical relevance. The ability of insulin to reduce sclerostin, possibly promoting bone formation, needs to be clarified.
|
|
7. |
|
|
8. |
|
|
9. |
|
|
10. |
|
|